ADME Toxicology Testing Market - 2024-2031
ADME Toxicology Testing Marketis is growing with a CAGR of 10.00% during the forecast period 2026-2035.
The ADME Toxicology Testing Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A ADME Toxicology Testing Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Technology
Both primary and secondary data sources have been used in the global ADME Toxicology Testing Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
The ADME Toxicology Testing Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A ADME Toxicology Testing Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Technology
- Cell Culture*
- High Throughput
- Molecular Imaging
- OMICS Imaging
- Cellular Assay*
- Biochemical Assay
- In-Silica Assays
- Ex-Vivo Assays
- Systemic Toxicity*
- Renal Toxicity
- Hepatotoxicity
- Neurotoxicity
- Others
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
- Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
- South America (Colombia, Brazil, Argentina, Rest of South America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
- Go-to-market Strategy.
- Neutral perspective on the market performance.
- Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
- Customized regional/country reports as per request and country level analysis.
- Potential & niche segments and regions exhibiting promising growth covered.
- Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Both primary and secondary data sources have been used in the global ADME Toxicology Testing Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
1. METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Market Snippet by Technology
3.2. Market Snippet by Method
3.3. Market Snippet by Application
3.4. Market Snippet by Region
4. GLOBAL ADME TOXICOLOGY TESTING MARKET-MARKET DYNAMICS
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. The rise in health spending globally
4.1.1.2. The rapid increase in demand for ADME toxicology testing in drug discovery
4.1.2. Restraints
4.1.2.1. Lack of skilled professional
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Value Chain Analysis
5.4. PEST Analysis
5.5. Pricing Analysis
5.6. Regulatory Analysis
5.7. Reimbursement Analysis
5.8. Unmet Needs
5.9. Patent Trends
6. COVID-19 ANALYSIS
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. BY TECHNOLOGY
7.1. Introduction
7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Segment
7.3. Market Attractiveness Index, By Technology Segment
7.3.1. Cell Culture*
7.3.1.1. Introduction
7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
7.3.2. High Throughput
7.3.3. Molecular Imaging
7.3.4. OMICS Imaging
8. BY METHOD
8.1. Introduction
8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method Segment
8.3. Market Attractiveness Index, By Method Segment
8.3.1. Cellular Assay*
8.3.1.1. Introduction
8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
8.3.2. Biochemical Assay
8.3.3. In-Silica Assays
8.3.4. Ex-Vivo Assays
9. BY APPLICATION
9.1. Introduction
9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
9.3. Market Attractiveness Index, By Application Segment
9.3.1. Systemic Toxicity*
9.3.1.1. Introduction
9.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
9.3.2. Renal Toxicity
9.3.3. Hepatotoxicity
9.3.4. Neurotoxicity
9.3.5. Others
10. BY REGION
10.1. Introduction
10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
10.3. Market Attractiveness Index, By Region
10.4. North America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. The U.S.
10.4.6.2. Canada
10.4.6.3. Mexico
10.5. Europe
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. Germany
10.5.6.2. The U.K.
10.5.6.3. France
10.5.6.4. Italy
10.5.6.5. Spain
10.5.6.6. Rest of Europe
10.6. South America
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.6.6.1. Brazil
10.6.6.2. Argentina
10.6.6.3. Rest of South America
10.7. Asia Pacific
10.7.1. Introduction
10.7.2. Key Region-Specific Dynamics
10.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
10.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
10.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.7.6.1. China
10.7.6.2. India
10.7.6.3. Japan
10.7.6.4. Australia
10.7.6.5. Rest of Asia Pacific
10.8. The Middle East and Africa
10.8.1. Introduction
10.8.2. Key Region-Specific Dynamics
10.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
10.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
10.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11. COMPETITIVE LANDSCAPE
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. COMPANY PROFILES
12.1. Accelrys, Inc.*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Key Highlights
12.1.4. Financial Overview
12.2. Agilent Technologies
12.3. Albany Molecular Research Inc.
12.4. ALS Ltd.
12.5. Beckman Coulter, Inc.
12.6. Bio-Rad Laboratories, Inc.
12.7. Charles River Laboratories International, Inc.
12.8. Covance, Inc. (LabCorp)
12.9. Eurofins Scientific SE
12.10. Life Technologies Corporation
12.11. Miltenyi Biotec
12.12. Promega Corporation
12.13. SGS Group
12.14. Thermo Fisher Scientific Inc.
12.15. WuXi AppTec
13. DATAM INTELLIGENCE
13.1. Appendix
13.2. About Us and Services
13.3. Contact Us
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Market Snippet by Technology
3.2. Market Snippet by Method
3.3. Market Snippet by Application
3.4. Market Snippet by Region
4. GLOBAL ADME TOXICOLOGY TESTING MARKET-MARKET DYNAMICS
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. The rise in health spending globally
4.1.1.2. The rapid increase in demand for ADME toxicology testing in drug discovery
4.1.2. Restraints
4.1.2.1. Lack of skilled professional
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Value Chain Analysis
5.4. PEST Analysis
5.5. Pricing Analysis
5.6. Regulatory Analysis
5.7. Reimbursement Analysis
5.8. Unmet Needs
5.9. Patent Trends
6. COVID-19 ANALYSIS
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. BY TECHNOLOGY
7.1. Introduction
7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Segment
7.3. Market Attractiveness Index, By Technology Segment
7.3.1. Cell Culture*
7.3.1.1. Introduction
7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
7.3.2. High Throughput
7.3.3. Molecular Imaging
7.3.4. OMICS Imaging
8. BY METHOD
8.1. Introduction
8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method Segment
8.3. Market Attractiveness Index, By Method Segment
8.3.1. Cellular Assay*
8.3.1.1. Introduction
8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
8.3.2. Biochemical Assay
8.3.3. In-Silica Assays
8.3.4. Ex-Vivo Assays
9. BY APPLICATION
9.1. Introduction
9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
9.3. Market Attractiveness Index, By Application Segment
9.3.1. Systemic Toxicity*
9.3.1.1. Introduction
9.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
9.3.2. Renal Toxicity
9.3.3. Hepatotoxicity
9.3.4. Neurotoxicity
9.3.5. Others
10. BY REGION
10.1. Introduction
10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
10.3. Market Attractiveness Index, By Region
10.4. North America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. The U.S.
10.4.6.2. Canada
10.4.6.3. Mexico
10.5. Europe
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. Germany
10.5.6.2. The U.K.
10.5.6.3. France
10.5.6.4. Italy
10.5.6.5. Spain
10.5.6.6. Rest of Europe
10.6. South America
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.6.6.1. Brazil
10.6.6.2. Argentina
10.6.6.3. Rest of South America
10.7. Asia Pacific
10.7.1. Introduction
10.7.2. Key Region-Specific Dynamics
10.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
10.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
10.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.7.6.1. China
10.7.6.2. India
10.7.6.3. Japan
10.7.6.4. Australia
10.7.6.5. Rest of Asia Pacific
10.8. The Middle East and Africa
10.8.1. Introduction
10.8.2. Key Region-Specific Dynamics
10.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
10.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
10.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11. COMPETITIVE LANDSCAPE
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. COMPANY PROFILES
12.1. Accelrys, Inc.*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Key Highlights
12.1.4. Financial Overview
12.2. Agilent Technologies
12.3. Albany Molecular Research Inc.
12.4. ALS Ltd.
12.5. Beckman Coulter, Inc.
12.6. Bio-Rad Laboratories, Inc.
12.7. Charles River Laboratories International, Inc.
12.8. Covance, Inc. (LabCorp)
12.9. Eurofins Scientific SE
12.10. Life Technologies Corporation
12.11. Miltenyi Biotec
12.12. Promega Corporation
12.13. SGS Group
12.14. Thermo Fisher Scientific Inc.
12.15. WuXi AppTec
13. DATAM INTELLIGENCE
13.1. Appendix
13.2. About Us and Services
13.3. Contact Us
